HLA 1–3 Antigen-Mismatched Related Peripheral Blood Stem Cells Transplantation Using Low-Dose Antithymocyte Globulin versus Unrelated Cord Blood Transplantation

Researchers evaluated 7861 patients with hematologic malignancies who received either a cord blood transplantr without anti-thymocyte globulin (ATG) or an HLA 1-3 antigen–mismatched related donor peripheral blood stem-cell transplantation using low-dose ATG.